About
Nostos Genomics is an AI-driven platform focused on transforming the clinical genomics workflow, particularly around the complex and time-intensive task of variant interpretation. Clinical laboratories and genetic counselors routinely face a bottleneck when manually curating evidence for thousands of genetic variants identified through sequencing. Nostos addresses this by leveraging machine learning and natural language processing to automatically aggregate relevant scientific literature, population databases, and clinical evidence, then applying established classification frameworks such as ACMG/AMP guidelines to suggest variant classifications. The platform is designed for clinical geneticists, molecular pathologists, and genomics labs that need to scale their diagnostic output without sacrificing accuracy or compliance. Key capabilities include automated evidence retrieval, AI-assisted variant scoring, and structured reporting tools that integrate into existing laboratory information systems. By dramatically reducing the time spent on each variant, Nostos enables labs to handle larger patient volumes and improve turnaround times for genetic diagnoses. Nostos Genomics is particularly valuable in rare disease diagnostics, oncology genomics, and population-scale sequencing programs where variant interpretation is a critical bottleneck. Its AI models are trained on curated genomic and clinical datasets, helping ensure outputs are both clinically relevant and audit-ready. The platform targets enterprise clinical labs, hospital genomics departments, and genomics service providers looking to modernize and automate their interpretation pipelines.
Key Features
- Automated Evidence Curation: AI automatically retrieves and aggregates relevant literature, population databases, and clinical data for each variant, eliminating hours of manual research.
- ACMG/AMP-Aligned Variant Classification: Applies established clinical variant classification guidelines automatically, providing AI-assisted scoring and classification suggestions.
- Scalable Clinical Workflow Integration: Integrates with existing laboratory information systems and reporting pipelines to scale interpretation throughput without disrupting established workflows.
- NLP-Powered Literature Mining: Uses natural language processing to extract clinically relevant insights from scientific publications and curated genomic knowledge bases.
- Audit-Ready Structured Reporting: Generates structured, traceable variant reports with evidence trails that meet clinical and regulatory standards.
Use Cases
- Clinical diagnostic labs automating ACMG/AMP variant classification to reduce analyst workload and improve turnaround times.
- Rare disease genomics programs interpreting large panels of candidate variants from whole exome or genome sequencing.
- Oncology genomics labs classifying somatic and germline variants for precision oncology decision support.
- Hospital genomics departments scaling their diagnostic output to meet growing patient sequencing demand.
- Genomics service providers standardizing and auditing variant interpretation workflows across multiple client accounts.
Pros
- Dramatic Time Savings: Automates the most time-consuming parts of variant interpretation, allowing labs to process significantly more cases per analyst.
- Clinically Validated Approach: Built around established ACMG/AMP guidelines, ensuring AI outputs align with accepted clinical practice standards.
- Enterprise-Ready Integration: Designed to slot into existing clinical genomics pipelines and LIMS without requiring a full workflow overhaul.
Cons
- Enterprise Pricing: Positioned as an enterprise solution, making it potentially inaccessible for smaller labs or academic groups with limited budgets.
- Limited Public Transparency: Pricing, model details, and product documentation are not publicly available, requiring direct sales engagement to evaluate.
- Niche Use Case: Highly specialized for clinical genomics; not applicable to general bioinformatics or non-clinical research contexts.
Frequently Asked Questions
What is Nostos Genomics used for?
Nostos Genomics is used to automate and accelerate the interpretation of genetic variants in clinical laboratory settings, reducing the manual effort required to classify variants according to guidelines like ACMG/AMP.
Who is the target user of Nostos Genomics?
The platform is designed for clinical geneticists, molecular pathologists, genetic counselors, and enterprise genomics labs — particularly those handling high volumes of sequencing data in rare disease, oncology, or population genomics.
How does the AI interpret genomic variants?
The AI aggregates evidence from scientific literature, population databases, and clinical resources using NLP and machine learning, then applies structured classification criteria to suggest variant pathogenicity classifications.
Does Nostos Genomics integrate with existing lab systems?
Yes, Nostos is built to integrate with laboratory information systems (LIMS) and existing clinical genomics pipelines via API, minimizing disruption to current workflows.
Is Nostos Genomics suitable for small labs or academic research?
Nostos Genomics is primarily enterprise-focused. Smaller labs or academic institutions should contact their sales team to discuss whether their offerings fit budget and use case requirements.
